Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 31 through 40 of 48 results (Download Results)

Show results per page

Variations on a theme: New approaches to examine SARS-CoV-2 variants and their ABO connections

West, Lori J | University of Alberta | Operating Grant | $482,935

CIHR Alberta 2021

COVID-19 Variant Supplement – Wastewater surveillance of SARS-COV2 to enable real-time clinical case-finding in Calgary

Parkins, Michael D | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Household Transmission Dynamics and Vial Load among Asymptomatic SARS-CoV-2 Infected Children

Freedman, Stephen B | The University of Calgary | Operating Grant | $49,932

CIHR Alberta 2021

Exploring Rehabilitation Needs and Access to Services for Long COVID

Gross, Douglas P | University of Alberta | Operating Grant | $152,778

CIHR Alberta 2021

COVID-19 Variant Supplement – Rapid, Ultrasensitive Clinical Detection of 2019 Novel Coronavirus (nCOVID-19) by Novel Microfluidic Electrochemical Nano-Biosensors

Sanati Nezhad, Amir | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract

Hobman, Tom C | University of Alberta | Operating Grant | $499,130

CIHR Alberta 2021

COVID-19 Variant Supplement – Therapeutic approaches to SARS-CoV-2 and other pathogenic coronaviruses

Hobman, Tom C | University of Alberta | Operating Grant | $49,533

CIHR Alberta 2021

COVID-19 Variant Supplement – Inferring undiagnosed sources of COVID‑19 infections using viral genomes

Long, Quan | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Supporting mental health and preventing moral injury among long term care+ workers: A mixed methods tool kit development and implementation study

Lashewicz, Bonnie M | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

Ng, Kenneth K | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Variations on a theme: New approaches to examine SARS-CoV-2 variants and their ABO connections

COVID-19 Variant Supplement – Wastewater surveillance of SARS-COV2 to enable real-time clinical case-finding in Calgary

COVID-19 Variant Supplement – Household Transmission Dynamics and Vial Load among Asymptomatic SARS-CoV-2 Infected Children

Exploring Rehabilitation Needs and Access to Services for Long COVID

COVID-19 Variant Supplement – Rapid, Ultrasensitive Clinical Detection of 2019 Novel Coronavirus (nCOVID-19) by Novel Microfluidic Electrochemical Nano-Biosensors

Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract

COVID-19 Variant Supplement – Therapeutic approaches to SARS-CoV-2 and other pathogenic coronaviruses

COVID-19 Variant Supplement – Inferring undiagnosed sources of COVID‑19 infections using viral genomes

COVID-19 Variant Supplement – Supporting mental health and preventing moral injury among long term care+ workers: A mixed methods tool kit development and implementation study

COVID-19 Variant Supplement – Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19